-
Study aim
-
Introducing a more effective treatment protocol to increase blood oxygen level, prevent disease progression, improve respiratory tidal volume and lung function in Covid 19 patients.
-
Design
-
Two groups, crossover, double blind, with random sequence by block randomization method on 30 patients. Random allocation software is used for randomization.
-
Settings and conduct
-
This clinical trial will be performed in Imam Khomeini Hospital. Patients are divided into two groups include the priority group of chest physiotherapy over the prone position and the priority group of prone position over the chest physiotherapy by using random sequencing method. Respiratory indicators will be recorded before the the first session and at the end of the last session for statistical analysis. The study is double blind and participants and evaluator and data analyst are blind to the type of intervention.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: 35 to 75 years old patients, affected by Covid 19, consciousness, in the progressive or acute phase of corona disease and similar in type and dose of medication received.
Exclusion criteria: patients under mechanical ventilation, with neurological disorders, undergoing surgery in the chest or abdomen area in the last 4 months, with blood coagulation disorders, with history of thrombosis or pulmonary embolism, with active bleeding in the chest area or rib fracture.
-
Intervention groups
-
Group 1: In 6 sessions, first chest physiotherapy (CPT) for 30 minutes and then for 3 hours prone position will be done.
group 2: In 6 sessions, first prone position for 3 hours and then CPT will be performed for 30 minutes.
-
Main outcome variables
-
oxygen saturation percentage(Spo2)؛ partial pressure of oxygen(Pao2)؛ fraction of inspired oxygen(Fio2)؛ Pao2/Fio2؛ forced vital capacity(FVC)؛ forced expiratory volume in first second(FEV1)؛ FEV1/FVC